Market closed
Rovi/ROVI
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Rovi
Laboratorios Farmaceuticos ROVI SA, ticker ROVI, is a Spain-based pharmaceutical company primarily engaged in developing, manufacturing, and commercializing pharmaceutical products. The company's activities span both domestic and international markets, focusing on a range of medical and drug treatments. Founded in 1946, ROVI continues to expand its reach and influence in the healthcare and pharmaceutical sectors.
Ticker
ROVI
Sector
Trading on
BME
Industry
Pharmaceuticals
Headquarters
Employees
2,137
Website
Rovi Metrics
BasicAdvanced
€3.9B
Market cap
26.85
P/E ratio
€2.84
EPS
0.51
Beta
€0.89
Dividend rate
1.17%
Dividend yield
Price and volume
Market cap
€3.9B
Beta
0.51
52-week high
€94.80
52-week low
€46.78
Average daily volume
80K
Dividend rate
€0.89
Financial strength
Current ratio
1.985
Quick ratio
0.66
Long term debt to equity
20.33
Total debt to equity
25.097
Dividend payout ratio (TTM)
46.64%
Interest coverage (TTM)
101.17%
Management effectiveness
Return on assets (TTM)
13.57%
Return on equity (TTM)
29.52%
Valuation
Price to earnings (TTM)
26.849
Price to revenue (TTM)
5.109
Price to book
8.53
Price to tangible book (TTM)
9.05
Price to free cash flow (TTM)
114.311
Dividend yield (TTM)
1.17%
Forward dividend yield
1.17%
Growth
Revenue change (TTM)
-4.91%
Earnings per share change (TTM)
-18.50%
3-year revenue growth (CAGR)
14.46%
3-year earnings per share growth (CAGR)
23.97%
3-year dividend per share growth (CAGR)
42.53%
What the Analysts think about Rovi
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Rovi stock.
Rovi Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Rovi Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe
FAQs
What’s the current market cap for Rovi stock?
Rovi (ROVI) has a market cap of €3.9B as of October 24, 2024.
What is the P/E ratio for Rovi stock?
The price to earnings (P/E) ratio for Rovi (ROVI) stock is 26.85 as of October 24, 2024.
Does Rovi stock pay dividends?
Yes, the Rovi (ROVI) stock pays dividends to shareholders. As of October 24, 2024, the dividend rate is €0.89399 and the yield is 1.17%. Rovi has a payout ratio of 46.64% on a trailing twelve-month basis.
When is the next Rovi dividend payment date?
The next Rovi (ROVI) dividend payment date is unconfirmed.
What is the beta indicator for Rovi?
Rovi (ROVI) has a beta rating of 0.51. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.